High-Dose Ambroxol in GBA1-Related Parkinson

Clinical trial NCT06193421 · UNKNOWN

Trial details

NCT number: NCT06193421
Sponsor: Agyany Pharma LTD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson Disease GBA Gene Mutation

Start date: 2023-10-24
Primary completion: 2025-02-27
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.